Find a trial Find a Pfizer clinical trial Refine your searchSearch Show filtersFilter byLocationPediatric Trials: 0-17 YearsAdult Trials: 18+ YearsAge (years)Sex Sex- Any -MaleFemaleBothMaleFemaleTrial status Indicates the current stage of a clinical study and whether it is or will be open for enrollment or in currently active and enrolling in the near future.Distance (miles)50100150200250+250+Travel DistanceAll0-50 miles0-100 miles0-150 miles0-200 miles1000Find a trialSearching for Matching Trials ...Join PfizerLink — a clinical research registryGet notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit. Sign upJoin PfizerLink — a clinical research registryGet notified about vitiligo clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit. Sign upJoin PfizerLink — a clinical research registryGet notified about atopic dermatitis clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit. Sign upJoin PfizerLink — a clinical research registryGet notified about eczema clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit. Sign upJoin PfizerLink — a clinical research registryGet notified about breast cancer clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit. Sign up8 trials found for LymphomaEmailPrint All (8) Recruiting (8) Not yet recruiting (0)Save searchSaved trialsCastration Resistant Prostate Cancer (CRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier. NCT03460977RecruitingMale or Female18+ years94study location(s) PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaRecruitingLymphoma, Multiple Myeloma, Acute Myeloid Leukemia, Diffuse Large B-Cell LymphomaA Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier. NCT03530683RecruitingMale or Female18+ years76study location(s) A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple MyelomaRecruitingNSCLC, ALCL, IMTCrizotinib Continuation Clinical Study NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier. NCT05160922RecruitingMale or Female1-99years5study location(s) Crizotinib Continuation Clinical StudyRecruitingDiffuse Large B-Cell LymphomaEffects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier. NCT05626322RecruitingMale or Female18+ years10study location(s) Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell LymphomaRecruitingLymphoma, Multiple MyelomaA Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier. NCT05567887RecruitingMale or Female18+ years3study location(s) A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic MalignanciesRecruitingCarcinoma, Non-Small-Cell LungStudy of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier. NCT04362072RecruitingMale or Female18+ years82study location(s) Study of Lorlatinib In People With ALK-positive Non-small Cell Lung CancerRecruitingNon-Small-Cell Lung Cancer, NSCLCLorlatinib Continuation Study NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier. NCT05144997RecruitingMale or Female18+ years20study location(s) Lorlatinib Continuation StudyRecruitingSolid TumorPF-07284892 in Participants With Advanced Solid Tumors NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier. NCT04800822RecruitingMale or Female18+ years14study location(s) PF-07284892 in Participants With Advanced Solid TumorsRecruiting Saved trialsContact usFor more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.
